Interleukin-6 (human) ELISA Kit

Confirm delete?

Zoom

Cat No: 501030

Assay Kits - Elisa

Interleukin-6 (IL-6) is produced by multiple cell types, including monocytes, macrophages, and T cells and is involved in many defense mechanisms including the immune response, hematopoiesis, bone metabolism, and acute phase reactions. IL-6 promotes t...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Scientific Literature
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

cytokine immunometrics kits assays measures measurements EIAs ELISAs enzymes immunoassays immunosorbents interleukins IL6 IL 6 amino acids polypeptides cells types monocytes macrophages T phosphorylations glycosylations post-translational modifications tissues defenses mechanisms immunity immune responses hematopoiesis bones metabolisms acute phases reactions rxns promotes proliferations activated B-cells B differentiations factors stimulates secretions immunoglobulins naive TH17 effectors diseases states bacterials viral infections HIV human immunodeficiency virus autoimmune cancers 583361 NASH non-alcoholic nonalcoholic steatohepatitis NAFLD nonalcoholic fatty liver disease

Product Overview:
Interleukin-6 (IL-6) is produced by multiple cell types, including monocytes, macrophages, and T cells and is involved in many defense mechanisms including the immune response, hematopoiesis, bone metabolism, and acute phase reactions. IL-6 promotes the proliferation of activated B-cells, acts as a B-cell differentiation factor, and stimulates the secretion of immunoglobulins. It also induces the differentiation of naïve T cells into TH17 effector cells. Cayman’s IL-6 (human) ELISA Kit is an immunometric (i.e., sandwich) ELISA that permits IL-6 measurements within the range of 7.8-250 pg/ml, with an LLOQ of 7.8 pg/ml.

Size	96 wells
Shipping	wet ice
Custom Code	3822.19
UNSPSC code	41116104

Grassi, J., Roberge, C.J., Frobert, Y., et al. Determination of IL1?, IL1? and IL2 in biological media using specific enzyme immunometric assays. Immunol Rev 119 125-142 (1991).

Van Damme, J., Opdenakker, G., Simpson, R.J., et al. Identification of the hu

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.